07:00 , Aug 5, 2013 |  BC Week In Review  |  Financial News

PolyTherics completes venture financing

PolyTherics Ltd. , London, U.K.   Business: Drug delivery   Date completed: 7/26/13   Type: Venture financing   Raised: £13.5 million ($20.8 million)   Investors: Imperial Innovations Group; Invesco; Mercia Fund Management; Advantage Enterprise &...
07:00 , Aug 5, 2013 |  BC Week In Review  |  Company News

Antitope, PolyTherics deal

PolyTherics merged with Antitope, which will operate as a wholly owned PolyTherics subsidiary. PolyTherics said the subsidiary will provide immunogenicity testing, antibody humanization and protein re-engineering technologies, including Antitope's EpiScreen, Composite Human Antibody and Composite...